Evidence map›Paper›PMID 32344262›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2020

Investigation of the evolution of radiation-induced lung damage using serial CT imaging and pulmonary function tests.

Catarina Veiga, Edward Chandy, Joseph Jacob, Natalie Yip, Adam Szmul, David Landau, Jamie R McClelland

Open access · hybridAbstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Long-term pulmonary function decline after stereotactic body radiation therapy for lung tumors.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Efficacy of Radiotherapy FLASH-RT: From Treating Lung Cancer to Preventing Pulmonary Fibrosis.Dose-response : a publication of International Hormesis Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Catarina VeigaCentre for Medical Image Computing, Department of Medical Physics & Biomedical Engineering, University College London, UK. Electronic address: c.veiga@ucl.ac.uk.
Edward ChandyUCL Cancer Institute, University College London, UK.
Joseph JacobCentre for Medical Image Computing, Department of Medical Physics & Biomedical Engineering, University College London, UK; Department of Respiratory Medicine, University College London, UK.
Natalie YipCentre for Medical Image Computing, Department of Medical Physics & Biomedical Engineering, University College London, UK.
Adam SzmulCentre for Medical Image Computing, Department of Medical Physics & Biomedical Engineering, University College London, UK.
David LandauDepartment of Oncology, University College London Hospital, UK; Department of Clinical Oncology, Guy's & St Thomas' NHS Foundation Trust, UK.
Jamie R McClellandCentre for Medical Image Computing, Department of Medical Physics & Biomedical Engineering, University College London, UK.
University College London · GBCRUK Lung Cancer Centre of Excellence · GBUniversity College Hospital · GB

Funding

Cancer Research UK 21993Cancer Research UK C13530/A10424Cancer Research UK C13530/A17007Wellcome TrustWellcome Trust 209553/Z/17/Z
6 · The paper itself

Abstract

background and purposeRadiation-induced lung damage (RILD) is a common consequence of lung cancer radiotherapy (RT) with unclear evolution over time. We quantify radiological RILD longitudinally and correlate it with dosimetry and respiratory morbidity. MATERIALS AND

methodsCTs were available pre-RT and at 3, 6, 12 and 24-months post-RT for forty-five subjects enrolled in a phase 1/2 clinical trial of isotoxic, dose-escalated chemoradiotherapy for locally advanced non-small cell lung cancer. Fifteen CT-based measures of parenchymal, pleural and lung volume change, and anatomical distortions, were calculated. Respiratory morbidity was assessed with the Medical Research Council (MRC) dyspnoea score and spirometric pulmonary function tests (PFTs): FVC, FEV

resultsFEV

conclusionsCT-based measures enable detailed quantification of the longitudinal evolution of RILD. The majority of patients developed progressive lung damage, even when the early phase was absent or mild. Pre-RT lung function and RT dosimetry may allow to identify subjects at increased risk of RILD.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansLungRespiratory Function TestsTomography, X-Ray ComputedComputed tomography (CT)LungPulmonary function test (PFT)Radiation-induced lung damage (RILD)

Identifiers

PMID32344262
PMCPMC7416106
OpenAlexW3013217676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.